Want to join the conversation?
$OKE 2Q15 Call: Starting the partnership, EBITDA contribution continues to ramp up and strong volume growth is shaping up as anticipated. We expect to grow our EBITDA on the 2H15 and be within our 2015 financial guidance range of $1.51-1.73Bil. Our EBITDA growth follows the volume growth.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.